Dyslipidemia and cardiovascular disease risk factors in patients with type 1 diabetes: A
single-center experience - PMC Back to Top Skip to main content NIH NLM Logo Access keys …

Abstract Introduction: Diabetes mellitus (DM), a chronic metabolic noncommunicable
disease (NCD), has assumed epidemic proportions worldwide. Type 2 diabetes (T2D) is …

Background Youth onset type 1 diabetes (T1D) and type 2 diabetes (T2D) is increasing and
associated with earlier vascular complications and mortality. Dyslipidemia is an important …

Lipid management for cardiovascular risk reduction in type 1... : Current Opinion in
Endocrinology, Diabetes and Obesity Lipid management for cardiovascular risk reduction in type …

Abstract Purpose of Review Cardiovascular (CV) disease is a major cause of mortality in
type 2 diabetes mellitus (T2D). Dyslipidemia is prevalent in children with T2D and is a …

Background: Cardiovascular disease (CVD) as a result of macrovascular changes is the
leading cause of mortality in patients with type 1 diabetes (T1DM). While CVD complications …

Cardiovascular disease (CVD) is the leading cause of death in Type 1 Diabetes (T1D). The
molecular basis for atherosclerosis in T1D is heavily influenced by hyperglycaemia and its …

Dyslipidaemia is an important modifiable risk factor contributing to the increased risk of
atherosclerotic cardiovascular disease in diabetes. However, determining when to initiate …

Abstract Purpose of Review In this review, we discuss the prevalence of cardiovascular
disease in people with type 1 diabetes. We outline key risk factors associated with increased …

Background: The prevalence of T1DM is increasing markedly. It is suggested that it will be
an epidemic of type 1 diabetes (T1DM) by 2025. T1DM is a major risk factor for CVD. The …